[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Martin Roper, CEO and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock on 09/12/2025 executed under a Rule 10b5-1 trading plan. The filing shows four sell transactions of 5,000 shares each at weighted-average prices around $40.01, reducing the reporting person's direct beneficial ownership to 352,062 shares. Separate lines show indirect holdings of 286,131 shares held by each of three family trusts and 61,200 shares held by a spouse. The form also discloses multiple fully vested and outstanding non-qualified stock options with various exercise prices and vesting schedules, including options exercisable for 579,670 shares and others vesting through 2035.

Positive

• Sales were executed under a Rule 10b5-1 trading plan, indicating pre-arranged dispositions rather than opportunistic trades
• Reporting person retains substantial equity and option holdings, including a fully vested option covering 579,670 shares

Negative

• Insider sold 20,000 shares on 09/12/2025, reducing direct ownership to 352,062 shares

Insights

Financial Analyst

TL;DR: Insider sales under a 10b5-1 plan reduced direct holdings but left substantial equity and many vested options.

The Form 4 documents systematic sales totaling 20,000 common shares on 09/12/2025, executed pursuant to a Rule 10b5-1 plan, at weighted-average prices near $40. These transactions lowered the reporting person's direct stake to 352,062 shares while sizable indirect holdings remain via family trusts and spouse. The filing also lists large option positions, including a fully vested option covering 579,670 shares exercisable at $10.178 and multiple other option tranches with exercise prices through $32.78 and vesting into 2035. For investors, this shows liquidity-taking by an insider without elimination of meaningful ownership and with substantial option-based incentives remaining.

Corporate Governance Expert

TL;DR: Sales appear routine and pre-planned; continued indirect family holdings and long-dated options indicate ongoing alignment.

The filing explicitly states the sales were made under a Rule 10b5-1 trading plan, which typically signals pre-arranged, non-tactical dispositions. Direct ownership was reduced to 352,062 shares while identical indirect balances (286,131) are reported for three family trusts, and 61,200 shares are held by a spouse, reflecting concentrated family ownership. Multiple non-qualified stock options—including a large fully vested tranche—remain outstanding, preserving incentive alignment. No amendments or unusual disclosures are present in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		S(1)		5,000	D	$40.015(2)	352,062	D
Common Stock	09/12/2025		S(1)		5,000	D	$40.008(3)	286,131	I	by Chris Roper FT(4)
Common Stock	09/12/2025		S(1)		5,000	D	$40.005(5)	286,131	I	by Peter Roper FT(6)
Common Stock	09/12/2025		S(1)		5,000	D	$40.019(7)	286,131	I	by Thomas Roper FT(8)
Common Stock								61,200	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(9)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (right to buy)	$10.178							(10)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(11)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(12)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(13)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(14)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These shares are held by the Christopher G. Roper Exempt Family Trust.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

6. These shares are held by the Peter S. Roper Exempt Family Trust.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. These shares are held by the Thomas L. Roper Exempt Family Trust.

9. The stock option is fully vested and currently exercisable.

10. The stock option is fully vested and currently exercisable.

11. The stock option vests in four equal annual installments beginning on November 27, 2022.

12. The stock option vests in four equal annual installments beginning on March 10, 2024.

13. The stock option vests in four equal annual installments beginning on March 4, 2025.

14. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Martin Roper	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions are reported for Martin Roper on Form 4 for COCO?

The Form 4 reports four sales of 5,000 common shares each on 09/12/2025 (totaling 20,000 shares) executed under a Rule 10b5-1 plan.

How many shares does Martin Roper directly own after the reported sales?

The filing shows 352,062 shares beneficially owned directly following the reported transactions.

Are there indirect holdings disclosed for the reporting person in the COCO Form 4?

Yes. The Form 4 discloses 286,131 shares held by each of three family trusts and 61,200 shares held by a spouse as indirect beneficial ownership.

Does the Form 4 disclose any stock options for Martin Roper?

Yes. Multiple non-qualified stock options are reported, including a fully vested option for 579,670 shares exercisable at $10.178, and other option tranches with exercise prices through $32.78 vesting up to 2035.

Were the reported sales single transactions or multiple trades?

The filing states the reported prices are weighted averages and that the shares were sold in multiple transactions at prices in specified ranges around $40.00.